The Orchard Strategy

Last month, I was in my doctor’s waiting room, watching the receptionist wrestle with three different computer systems just to book my checkup. She clicked through windows that looked like they belonged on a floppy disk.

“This is why healthcare costs so much,” I thought.

What I didn’t realize then was that I was watching the very problem UnitedHealth Group (UNH) is spending billions to fix, and why the company is worth paying attention to, even after its latest missteps.

Most people still think of UnitedHealth as an insurance company. That’s like calling Amazon (AMZN) a bookseller.

The truth is, UnitedHealth has quietly become something much bigger: a healthcare technology company with an insurance arm attached.

Optum, its data and services division, already brings in almost as much revenue as insurance.

Together, they pushed the company past $400 billion in 2024 revenue, up 8% from the year before. But profits slipped. Margins fell from 4.3% to 3.1% because management badly miscalculated medical costs. A $6.5 billion mistake, to be exact.

That sounds ugly. But to focus only on the miss is to miss the story.

UnitedHealth is trying to drag American healthcare into a different universe: one where doctors are rewarded for keeping you healthy instead of billing you for every pill, test, and scan. It’s called value-based care.

In the old model, your cardiologist makes money when you’re on the operating table.

In the new model, they make money by keeping you off it.

It’s a shift so simple it feels obvious, yet so radical it threatens to rewrite the economics of an entire industry.

So, what’s the catch? Well, this new approach takes time.

The first patient groups UnitedHealth shifted in 2021 are now profitable, posting 8% margins. The newest groups are losing money.

It’s like planting an orchard. For years, you bleed cash. Then one season, the trees bear fruit, and suddenly, the numbers flip.

UnitedHealth is asking investors to wait for the harvest.

Its edge is data. Optum processes millions of patient interactions. It can see who’s at risk of diabetes before symptoms show up, or who’s on the path to a heart attack, then step in when prevention is cheaper and more effective than a hospital bed.

That predictive power is the holy grail of modern medicine, and UnitedHealth is building it at scale.

Regulation makes the near-term story harder.

Premium increases take more than a year to approve. Federal rules require that 80 cents of every premium dollar be spent on care, capping profits.

Those guardrails squeeze margins, but they also raise barriers so high that smaller competitors don’t stand a chance.

UnitedHealth, in effect, plays on a field few others can afford to enter.

And the irony is that Wall Street is punishing UnitedHealth for the very thing that could make it unstoppable.

The stock trades cheaply compared with peers, as if investors believe margins will stay under pressure forever. Yet management is also projecting nearly a billion dollars in savings from artificial intelligence by 2026. These are tiny efficiency gains spread across hundreds of millions of patient encounters that add up to a fortune.

Yes, the risk is real. If UnitedHealth can’t make value-based care work at scale, it will be left with bloated costs and no payoff.

But the bigger truth is that the American healthcare system can’t go on as it is. Someone will figure out how to deliver better outcomes for less money.

UnitedHealth has the size, the data, and the resources to be that someone.

So when I see a receptionist clicking through 1995 software, I think less about the frustration and more about the opportunity. The system has to change. UnitedHealth is betting it can lead that change.

For those who can stomach a little short-term pain, buying the dip looks less like a gamble and more like planting trees for the long haul.